Journal article
Implications of private sector Hib vaccine coverage for the introduction of public sector Hib-containing pentavalent vaccine in India: evidence from retrospective time series data
Haemophilus influenzae type b (Hib) vaccine has been available in India\'s private sector market since 1997. It was not until 14 December 2011 that the Government of India initiated the phased public sector introduction of a Hib (and DPT, diphtheria, pertussis, tetanus)-containing pentavalent vaccine. Our objective was to investigate the state-specific coverage and behaviour of Hib vaccine in India when it was available only in the private sector market but not in the public sector. This baseline information can act as a guide to determine how much coverage the public sector rollout of pentavalent vaccine (scheduled April 2015) will need to bear in order to achieve complete coverage.
Authors
Languages
- English
Publication year
2015
Journal
BMJ Open
Volume
5
Type
Journal article
Categories
- Service delivery
Diseases
- Diphtheria
- HIB
Countries
- India
Tags
- Coverage monitoring
- New vaccine introduction
- Performance monitoring
WHO Regions
- South-East Asia Region
